Fore Biotherapeutics

Series-B+
fore.bio Biotech & Healthcare
Total Funding $40M
Latest Round Undisclosed Series-B+
Last Announced Jul 8, 2026
Investors Undisclosed
Decision Makers 5 Verified

About Fore Biotherapeutics

A precision oncology company rooted in science and innovation, pioneering the development of unique cancer therapies.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Undisclosed
Tracked Since Sep 29, 2026

Web & Domain Identity

Official Website fore.bio
Domain Registered Date Feb 12, 2021

Social & Network Presence

X / Twitter Profile @ForeBiotx (91 followers) Created on Feb 2021
LinkedIn Corporate Not linked

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Series-B+ announced

    startupintros.com

  2. Capital Raise

    Raised $40,000,000 · Series-B+

    startupintros.com

  3. Milestone

    X account created (@ForeBiotx)

    91 followers

  4. Milestone

    Website domain registered

    fore.bio

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Fore Biotherapeutics.

Funding History

2 Rounds
Series-B+ · Jul 8, 2026
Series-B+ · May 1, 2025

Founders & Leadership

1

Giovanni Mariggi

Co-founder and Partner at Medicxi

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts